Benzinga - Thu, 18 Feb 2021 17:54:11 -0400
Benzinga - Tue, 12 Jan 2021 17:38:32 -0400
Benzinga - Thu, 07 Jan 2021 08:09:57 -0400
Benzinga - Mon, 09 Nov 2020 18:10:08 -0400
Benzinga - Mon, 09 Nov 2020 17:28:03 -0400
Benzinga - Thu, 17 Sep 2020 05:04:19 -0400
Benzinga - Wed, 16 Sep 2020 12:25:00 -0400
load more
Sector: Health Care.Industry: Biotechnology
AVEO Pharmaceuticals Inc is a biopharmaceutical company dedicated to advancing a broad portfolio of targeted medicines for oncology and other areas of unmet medical need. The Company's aim is to retain North American rights to its oncology portfolio while securing partners in development and commercialization outside of North America. It is seeking to develop and commercialize its lead candidate tivozanib in North America as a treatment for advanced or metastatic renal cell carcinoma (RCC). It has outlicensed tivozanib (FOTIVDA) for oncology in Europe and other territories outside North America. Tivozanib is approved in the European Union as well as Norway and Iceland for the first-line treatment of adult patients with RCC.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-04-29
REV
Q4 2020Est.ActualSurprise
EPS
(EXPECTED)2021-03-19
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
AVEOAVEO Pharmaceuticals-0.73%233.9M

AVEO Pharmaceuticals Company Questions & Answers

Q

How do I buy AVEO Pharmaceuticals (AVEO) stock?

A

You can purchase shares of AVEO Pharmaceuticals (NASDAQ: AVEO) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are AVEO Pharmaceuticals's (AVEO) main competitors?

A

Other companies in AVEO Pharmaceuticals’s space includes: Galecto (NASDAQ:GLTO), Cabaletta Bio (NASDAQ:CABA) and Cogent Biosciences (NASDAQ:COGT).

Q

What is the target price for AVEO Pharmaceuticals?

A

The latest price target for AVEO Pharmaceuticals (NASDAQ: AVEO) was reported by SVB Leerink on 2021-01-19. The analyst firm set a price target for 10.00 expecting AVEO to rise to within 12 months (a possible 23.15% upside). 6 analyst firms have reported ratings in the last year.

Q

How much is AVEO Pharmaceuticals (AVEO) stock ?

A

The stock price for AVEO Pharmaceuticals (NASDAQ: AVEO) is $8.12 last updated Today at 6:25:07 PM.

Q

When is the next AVEO Pharmaceuticals (AVEO) dividend?

A

There are no upcoming dividends for AVEO Pharmaceuticals.

Q

When is AVEO Pharmaceuticals (NASDAQ:AVEO) reporting earnings?

A
AVEO Pharmaceuticals’s Q1 earnings are confirmed from now on April 29, 2021.
Q

When is the upcoming split for AVEO?

A

There is no upcoming split for AVEO Pharmaceuticals.